Regulation of the ROS Response Dynamics and Organization to PDGF Motile Stimuli Revealed by Single Nanoparticle Imaging
Cédric Bouzigues(Centre National de la Recherche Scientifique), Antigoni Alexandrou(Centre National de la Recherche Scientifique), Amy A. Claeson(Centre National de la Recherche Scientifique), Thanhliem Nguyen(Quy Nhon University), Rivo Ramodiharilafy(Centre National de la Recherche Scientifique), Pierre‐Louis Tharaux(Inserm)
Cited by 17
Related Papers
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
|JAMA Internal Medicine|2020|777
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
|Science Immunology|2021|638
Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial
|The Lancet Respiratory Medicine|2021|297
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
|Proceedings of the National Academy of Sciences|2022|198